New Trends in the Molecular and Biological Basis for Clinical Oncology

  • Tetsuhiko Tachikawa
  • Kiyoshi Nose
  • Tohru Ohmori
  • Mitsuru Adachi
Conference proceedings

Table of contents

  1. Front Matter
    Pages I-XXIII
  2. RTK-Related Signaling

    1. Front Matter
      Pages 1-1
    2. Kazuto Nishio, Tokuzo Arao
      Pages 29-36
    3. Toshimitsu Yamaoka, D. Brent Polk, Tohru Ohmori, Sojiro Kusumoto, Tomohide Sugiyama, Takao Shirai et al.
      Pages 37-54
    4. Tohru Ohmori, Takamichi Hosaka, Tomoko Kanome, Fumiko Inoue, Koichi Ando, Takashi Hirose et al.
      Pages 55-66
  3. Inflammation, Angiogenesis, and Tumor Progression

    1. Front Matter
      Pages 67-67
    2. Sophia Bornstein, Gang-Wen Han, Kristina Hoot, Shi-Long Lu, Xiao-Jing Wang
      Pages 69-80
    3. Kiyoshi Nose, Tadashi Sugimoto, Masami Wakamatsu, Fumihiro Ishikawa, Motoko Shibanuma
      Pages 81-85
  4. Biomarkers for Clinical Oncology

  5. Poster Session

    1. Front Matter
      Pages 125-125
    2. Sojiro Kusumoto, Tomohide Sugiyama, Masanao Nakashima, Toshimitsu Yamaoka, Takashi Hirose, Tsukasa Ohnishi et al.
      Pages 127-131
    3. Tsuyoki Kadofuku, Tomoko Kanome, Kazuto Nishio, Toshio Kuroki, Tohru Ohmori
      Pages 132-138
    4. Kazunori Mori, Yukiko Oshima, Kiyoshi Nose, Motoko Shibanuma
      Pages 139-152
    5. Gou Yamamoto, Taku Matsunaga, Tomohide Isobe, Tarou Irie, Tetsuhiko Tachikawa
      Pages 157-167
    6. Yuji Kurihara, Yuichi Watanabe, Tom Kojima, Tatsuo Shirota, Masashi Hatori, Yasuo Urata et al.
      Pages 168-183
    7. Sayaka Yoshiba, Daisuke Ito, Tatsuhito Nagumo, Tatsuo Shirota, Masashi Hatori, Satoru Shintani
      Pages 184-190
  6. Back Matter
    Pages 191-192

About these proceedings


Newly developed molecular target anticancer drugs have shown remarkable efficacy even in the treatment of intractable cancers such as hepatoma and renal cell carcinoma. As cancer research is becoming a multidisciplinary endeavor, close cooperation across the basic, translational, and clinical research fields holds the promise of further advances in cancer therapeutics. This book sets forth new strategies for development: cancer therapy targeting receptor tyrosine kinases with clinical utilization of new signaling regulations; interaction between cancer progression and extracellular environments such as inflammatory cytokines and the extracellular matrix; and investigation of biomarkers for personalized cancer therapy, with microarray analysis and pharmacogenomics technology. These and other findings from the latest investigations into cancer cell biology and therapeutics make this book an invaluable source for investigators in both the clinical and basic cancer research fields.


Cancer Screening angiogenesis cancer cancer therapy carcinoma cell cell biology cytokine cytokines genome genomics laser microarray renal cell carcinoma tumor

Editors and affiliations

  • Tetsuhiko Tachikawa
    • 1
  • Kiyoshi Nose
    • 2
  • Tohru Ohmori
    • 3
  • Mitsuru Adachi
    • 4
  1. 1.Department of Oral Pathology and DiagnosisShowa University School of DentistryTokyoJapan
  2. 2.Department of MicrobiologyShowa University School of Pharmaceutical SciencesTokyoJapan
  3. 3.Institute of Molecular OncologyShowa UniversityTokyoJapan
  4. 4.Division of Allergology and Respiratory Medicine, Department of Internal MedicineShowa University School of MedicineTokyoJapan

Bibliographic information

  • DOI
  • Copyright Information Springer Japan 2009
  • Publisher Name Springer, Tokyo
  • eBook Packages Medicine
  • Print ISBN 978-4-431-88662-4
  • Online ISBN 978-4-431-88663-1
  • Buy this book on publisher's site